Abstract
Introduction
Immune suppression is a crucial pillar for treatment of aplastic anemia. Cyclosporine monotherapy is an easily available, affordable therapeutic option with good safety profile.
Methods and Materials
This prospective study was conducted over a period of 2 years from June 2012 to July 2014. The diagnosis and response to treatment of aplastic anemia was established as per published criteria. Follow up was done at 3 and 6 months in order to assess the response.
Results
57 patients of acquired aplastic anemia with median age of 37 years (6 to 81 years) were included in the study. 35 (62 %) cases were severe aplastic anemai, 16 (28 %) non severe aplastic anemia and 6 (10 %) were very severe aplastic anemia. At 3 months overall response rate (OR) was 7 (14 %) and at 6 months the OR rate of 11 (19.6 %) was achieved. Transiently raised creatinine, liver function abnormality and gum hypertrophy were the main side effects observed in this cohort.
Conclusion
Oral cyclosporine monotherapy at dose of 5 mg/kg/day is a relatively safe treatment option for resource poor patients with aplastic anemia.
References
Young NS, Maciejewski J (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365–1372
Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D et al (1992) Multicentre randomized study comparing cyclosporin A alone and ATG with prednisone for the treatment of aplastic anemia. Blood 79:2540–2546
Camitta BM (2000) what is the definition of cure for aplastic anemia? Acta Haematol 103:16–18
Marsh J, Schrezenmeier H, Marin P et al (1999) Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93:2191–2195
Camitta BM (1984) Pathogenesis and treatment of aplastic anemia. RhinsoKetseuki 25:459–469
Malhotra P, Gella V, Guru Murthy GS, Varma N, Varma S (2015) High incidence of aplastic anemia is linked with lower socioeconomic status of Indian population. J Public Health. doi:10.1093/pubmed/fdv027: First published online: March 8, 2015
Dasgupta S, Mandal PK, Chakrabarti S (2015) Etiology of pancytopenia: an observation from a Referral Medical Institution of Eastern Region of India. J Lab Physicians 7:90–95
Chakrabarti S, Goswami BK, Paul PC, Sarkar S, Mondal S, Das S (2013) Clinico haematological profile of aplastic anaemia in a rural medical college of Northern West Bengal. J Indian Med Assoc 111:670–673
Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K, Kinashi M, Takahara J (1994) Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum 37:551–558
Hami M, Mojahedi MJ, Naghibi M, Shakeri MT, Sharifipour F (2010) Cyclosporine trough levels and its side effects in kidney transplant recipients. Iran J Kidney Dis 4:153–157
Authors Contribution
Contributor | Concept | Study design | Data collection | Statistical analysis | Literature overview | Discussion | Fund generation |
---|---|---|---|---|---|---|---|
Prakas Kumar Mandal | Yes | Yes | Yes | Yes | Yes | Yes | Nil |
Suvraneel Baul | Yes | Yes | Yes | Yes | Yes | Yes | Nil |
Tuphan Kanti Dolai | Yes | Yes | – | – | – | Yes | Nil |
Rajib De | Yes | Yes | – | – | – | Yes | Nil |
Prantar Chakrabarti | Yes | Yes | – | – | Yes | Yes | Nil |
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no competing interests.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee.
Rights and permissions
About this article
Cite this article
Mandal, P.K., Baul, S., Dolai, T.K. et al. Outcome of Cyclosporine Monotherapy in Patients of Aplastic Anemia: Experience of a Tertiary Care Hospital in Eastern India. Indian J Hematol Blood Transfus 33, 144–147 (2017). https://doi.org/10.1007/s12288-016-0706-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0706-7